ATE254929T1 - ORAL SOLUTION OF PRUCALOPRIDE - Google Patents

ORAL SOLUTION OF PRUCALOPRIDE

Info

Publication number
ATE254929T1
ATE254929T1 AT00931072T AT00931072T ATE254929T1 AT E254929 T1 ATE254929 T1 AT E254929T1 AT 00931072 T AT00931072 T AT 00931072T AT 00931072 T AT00931072 T AT 00931072T AT E254929 T1 ATE254929 T1 AT E254929T1
Authority
AT
Austria
Prior art keywords
prucalopride
oral solution
oral
solution
Prior art date
Application number
AT00931072T
Other languages
German (de)
Inventor
Proost Eddy Andre Josee De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE254929T1 publication Critical patent/ATE254929T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
AT00931072T 1999-04-29 2000-04-20 ORAL SOLUTION OF PRUCALOPRIDE ATE254929T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en) 1999-04-29 2000-04-20 Prucalopride oral solution

Publications (1)

Publication Number Publication Date
ATE254929T1 true ATE254929T1 (en) 2003-12-15

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931072T ATE254929T1 (en) 1999-04-29 2000-04-20 ORAL SOLUTION OF PRUCALOPRIDE

Country Status (36)

Country Link
US (1) US6413988B1 (en)
EP (1) EP1176982B1 (en)
JP (1) JP4773619B2 (en)
KR (1) KR100669175B1 (en)
CN (1) CN1165345C (en)
AR (1) AR023815A1 (en)
AT (1) ATE254929T1 (en)
AU (1) AU770073B2 (en)
BG (1) BG65061B1 (en)
BR (1) BRPI0010150B8 (en)
CA (1) CA2371178C (en)
CZ (1) CZ294070B6 (en)
DE (1) DE60006799T2 (en)
DK (1) DK1176982T3 (en)
EA (1) EA003904B1 (en)
EE (1) EE05264B1 (en)
ES (1) ES2211546T3 (en)
HK (1) HK1045950B (en)
HR (1) HRP20010764B1 (en)
HU (1) HU228924B1 (en)
ID (1) ID30397A (en)
IL (2) IL146152A0 (en)
JO (1) JO2181B1 (en)
MX (1) MXPA01010953A (en)
MY (1) MY119880A (en)
NO (1) NO331448B1 (en)
NZ (1) NZ515119A (en)
PL (1) PL195674B1 (en)
PT (1) PT1176982E (en)
SI (1) SI1176982T1 (en)
SK (1) SK284847B6 (en)
TR (1) TR200103121T2 (en)
TW (1) TW592709B (en)
UA (1) UA68426C2 (en)
WO (1) WO2000066170A1 (en)
ZA (1) ZA200108820B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
EP1347779A2 (en) * 2000-11-24 2003-10-01 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
RU2301806C2 (en) 2002-01-16 2007-06-27 Янссен Фармацевтика Н.В. Prucaloprid n-oxide
JP4526247B2 (en) * 2002-07-08 2010-08-18 第一三共株式会社 Oral cephalosporins
FI20022007A0 (en) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromucosal preparation and method of preparation thereof
US20070191283A1 (en) 2004-08-12 2007-08-16 Rejuvenon Corporation Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
GB201103397D0 (en) * 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (en) * 1991-12-13 1993-06-29 Kanebo Ltd Peroral liquid agent
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
JP2002530334A (en) 1998-11-23 2002-09-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Use of prucalopride for the manufacture of a medicament for the treatment of indigestion

Also Published As

Publication number Publication date
AU4913700A (en) 2000-11-17
TW592709B (en) 2004-06-21
BRPI0010150B8 (en) 2021-05-25
CN1348386A (en) 2002-05-08
DE60006799D1 (en) 2004-01-08
JO2181B1 (en) 2003-04-23
EP1176982A1 (en) 2002-02-06
EA200101150A1 (en) 2002-04-25
EE05264B1 (en) 2010-02-15
CZ20013735A3 (en) 2002-02-13
KR20020004972A (en) 2002-01-16
BR0010150A (en) 2002-01-15
NO20014794D0 (en) 2001-10-02
NO331448B1 (en) 2012-01-02
AU770073B2 (en) 2004-02-12
CA2371178C (en) 2008-03-25
SK284847B6 (en) 2006-01-05
IL146152A0 (en) 2002-07-25
JP4773619B2 (en) 2011-09-14
EA003904B1 (en) 2003-10-30
US6413988B1 (en) 2002-07-02
HK1045950A1 (en) 2002-12-20
BG65061B1 (en) 2007-01-31
ES2211546T3 (en) 2004-07-16
CN1165345C (en) 2004-09-08
HU228924B1 (en) 2013-06-28
HUP0202324A2 (en) 2002-12-28
TR200103121T2 (en) 2002-05-21
ID30397A (en) 2001-11-29
EE200100539A (en) 2002-12-16
MY119880A (en) 2005-07-29
PL195674B1 (en) 2007-10-31
NZ515119A (en) 2003-05-30
UA68426C2 (en) 2004-08-16
DK1176982T3 (en) 2004-03-29
HRP20010764B1 (en) 2011-01-31
BG106031A (en) 2002-05-31
SK15192001A3 (en) 2002-03-05
SI1176982T1 (en) 2004-04-30
NO20014794L (en) 2001-10-02
AR023815A1 (en) 2002-09-04
WO2000066170A1 (en) 2000-11-09
CZ294070B6 (en) 2004-09-15
EP1176982B1 (en) 2003-11-26
PL352062A1 (en) 2003-07-28
JP2002543161A (en) 2002-12-17
HK1045950B (en) 2005-05-27
PT1176982E (en) 2004-04-30
IL146152A (en) 2006-12-31
HRP20010764A2 (en) 2002-12-31
KR100669175B1 (en) 2007-01-17
ZA200108820B (en) 2003-01-27
CA2371178A1 (en) 2000-11-09
HUP0202324A3 (en) 2003-03-28
DE60006799T2 (en) 2004-09-23
BRPI0010150B1 (en) 2015-06-23
MXPA01010953A (en) 2002-05-06

Similar Documents

Publication Publication Date Title
FI991485A (en) New pharmaceutical composition
DE69928195D1 (en) Completion of Untrerdruck-boreholes
NO20003640D0 (en) New dosage form
ATE392890T1 (en) HYDROGEL-CONTROLLED DOSAGE FORM
DE69924365D1 (en) MASSAGER
NO20012915D0 (en) New pharmaceutical formulation
DK1637127T3 (en) THERAPEUTIC MICROSUM
ID27841A (en) THERAPEUTIC BIARILS
DE69823360D1 (en) SOLID MEDICAL CONSUMPTION CONTAINING BENZOFURANDERIVATE
NO992692L (en) Nefadozone dosage form
DK1466615T3 (en) Pharmaceutical preparation
DE60007530D1 (en) ORAL EFFECTIVE ANDROGENE
DE60025627D1 (en) PHARMACEUTICAL SOLUTION OF LEVOSIMENDAN
NO20005179D0 (en) Drug treatment
DE60019960D1 (en) PREPARATION OF ISOBUTENCOPOLYMERS
NO20022606L (en) Pharmaceutical combinations
DE60043058D1 (en) DENTAL MATERIALS
ATE309838T1 (en) PHARMACEUTICAL IMPLANT
ATE254929T1 (en) ORAL SOLUTION OF PRUCALOPRIDE
NO20013337L (en) New treatment
DE29900419U1 (en) Walker
NO20004816D0 (en) New pharmaceutical formulation
ID30381A (en) USE OF ARILALKANOILPIRIDAZINA
DE60010809D1 (en) processor
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1176982

Country of ref document: EP

EEIH Change in the person of patent owner
EEFA Change of the company name